Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • PhDstudent
    Junior Member
    • Aug 2014
    • 5

    Comment on my cDNA lib electropherograms - new to this

    Hi there,

    Just starting to make cDNA libraries and not sure how the electropherogram should look when I do fragment size analysis with Bioanalyzer High sensitivity DNA chip.

    So I used the KAPA Stranded mRNA-seq kit. Fragmentation is thermal, selecting for 200-300bp fragments.

    Goal is DE between drug treatments compared to control. Right now just troubleshooting to make sure our library prep is up to par before doing the real libraries.

    Sample 2: 2ug total eukaryotic RNA from mouse primary neuron culture with 10x PCR cycles
    Sample 4: 1ug same type of RNA with 10x PCR cycles
    Sample 5: 1ug same type of RNA with 8x PCR cycles

    My feeling is that Samples 2 & 4 are just over amplified/too much cDNA loaded for the high-sensitivity DNA chip.

    Please give me feedback on my electropherograms, would be very greatful for any positive or negative feedback.

    Cheers.
    Attached Files
  • pmiguel
    Senior Member
    • Aug 2008
    • 2328

    #2
    Sounds reasonable. If your PCR reaction becomes depleted for reactants, then you end up with "bubble products". That is, the ends of the amplicons are all basically the same sequences, so they can anneal even if their inserts don't match. So after denaturation if no product strand is created, then the single-stranded amplicon will likely run into another single-stranded amplicons and their ends with hybridize. These "bubble products" run strange on bioanalyzer chips -- aberrantly large for their molecular weight.

    --
    Phillip

    Comment

    • PhDstudent
      Junior Member
      • Aug 2014
      • 5

      #3
      Thanks for the response! Do you find though that the downstroke of the curve should be more abrupt similar to the upstroke of the curve?

      Comment

      • Jennifer Pavlica
        Junior Member
        • Feb 2015
        • 1

        #4
        Dear PhDstudent,

        I am a Sr. Support and Applications Scientist with Kapa Biosystems. After reviewing your BioAnalyzer traces, it appears that your libraries may be slightly overamplified, most noticeably in Sample 2. With future samples, I recommend decreasing the amplification by a cycle or two.

        However, it is probable that the root cause of the bimodal peaks observed in Samples 2 and 4 are a result of sample overloading on the High Sensitivity chip. Increasing the dilution factor prior to assessment on the BioAnalyzer should alleviate this issue.

        I hope you find this information useful.

        Best,

        Jennifer Pavlica

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        29 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        21 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        212 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        78 views
        0 reactions
        Last Post SEQadmin2  
        Working...